Piramal Pharma Share Price Target 2026: Expert Forecast, Catalysts and Key Risks
- May 12, 2026
- Posted by: Kashish Aggarwal
- Category: News
The Piramal Pharma share price target for 2026 stands at Rs 267 as per analyst forecast implying 20 to 40 percent upside from the current market price of Rs 220. Investors tracking the Piramal Pharma share price target 2026 need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the Piramal Pharma share price target thesis updated April 2026.
Click Here Get Free Investment Predictions on Univest
Track live Piramal Pharma price, FII/DII flows and analyst targets on the Univest Screener.
Piramal Pharma Company Overview
Tap to Access Best Research Pieces on Univest
Piramal Pharma (NSE: PPLPHARMA) is a listed company in India’s Pharmaceuticals CDMO Consumer Health sector with a market capitalisation of Rs 12,000 crore. At CMP Rs 220 against a 52 week range of Rs 165 to Rs 320, the stock currently offers meaningful upside to the analyst forecast Piramal Pharma share price target of Rs 267. For more share price target analysis, visit Univest Blogs.
| Parameter | Value |
|---|---|
| NSE Ticker | PPLPHARMA |
| Sector | Pharmaceuticals CDMO Consumer Health |
| CMP April 2026 | Rs 220 |
| 52 Week High | Rs 320 |
| 52 Week Low | Rs 165 |
| Market Cap | Rs 12,000 crore |
| Trailing P/E | 55x |
| 12M Analyst Target | Rs 267 |
| Bull Case Target | Rs 343 |
| Bear Case Target | Rs 163 |
Why Is Piramal Pharma Share Price Target Set at Rs 267 for 2026
FY27 Earnings Delivery and Revenue Acceleration
FY27 is the year where analysts expect Piramal Pharma to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 220 and the Piramal Pharma share price target 2026 of Rs 267. Analysts project 15 to 20 percent PAT growth in FY27. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the Piramal Pharma share price target forecast. Track Q4 results live on the Univest Screener.
Structural Sector Tailwinds in Pharmaceuticals CDMO Consumer Health
India’s Pharmaceuticals CDMO Consumer Health sector is expanding at 12 to 18 percent annually driven by urbanisation, rising incomes, government policy continuity, and the broad India growth narrative. Piramal Pharma’s market position within this expanding sector creates compounding runway that directly supports the Piramal Pharma share price target forecast of Rs 267. Discover top stocks on the Univest Screener.
RBI Rate Cut Cycle and Improving Macro Backdrop
India’s RBI rate cut cycle which commenced in 2026 reduces Piramal Pharma’s borrowing costs and stimulates end customer demand. Lower interest rates improve EBITDA to PAT conversion, directly expanding EPS and supporting the Piramal Pharma share price target 2026 of Rs 267. Compare Piramal Pharma with sector peers live on the Univest Screener.
Union Budget 2026 Policy Support
Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, continued PLI scheme support, and consumption demand incentives create a positive policy backdrop for Piramal Pharma’s Pharmaceuticals CDMO Consumer Health business, directly supporting the Piramal Pharma share price target 2026 bull case.
Improving FII Flows Post US Tariff Shock
As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the Piramal Pharma share price target of Rs 267. Track live FII/DII activity on the Univest Screener.
Piramal Pharma Share Price Targets Short Term 12 Month and Long Term
Download the Univest iOS App or Univest Android App to get daily stock recommendations and SEBI registered research.
Short Term Piramal Pharma Share Price Target 3 to 6 Months
The short term Piramal Pharma share price target is anchored to the 52 week low support zone near Rs 165. Subscribe to Univest Pro for SEBI registered entry, target, and stop loss recommendations on Piramal Pharma.
12 Month Piramal Pharma Share Price Target 2026
The 12 month analyst forecast Piramal Pharma share price target 2026 is Rs 267 implying 20 to 40 percent upside from CMP Rs 220. Track live targets on the Univest Screener.
Long Term Piramal Pharma Share Price Target FY27 to FY28
For investors with a 2 to 3 year horizon, the long term Piramal Pharma share price target is Rs 343 in the bull case. For more analysis, visit Univest Blogs.
Bull Case and Bear Case for Piramal Pharma Share Price Target
Bull Case Piramal Pharma Share Price Target Rs 343
The bull case for the Piramal Pharma share price target of Rs 343 materialises if FY27 earnings exceed forecast and the Pharmaceuticals CDMO Consumer Health sector benefits from a broad FII driven re-rating. Discover top stocks and live analyst targets on the Univest Screener.
Bear Case Piramal Pharma Share Price Target Rs 163
The bear case sees the Piramal Pharma share price target testing Rs 163 if FY27 guidance disappoints significantly and FII outflows from India persist. Track support levels on the Univest Screener.
| Scenario | Price Target | Conditions |
|---|---|---|
| Bull Case | Rs 343 | FY27 beat, macro normalisation, sector re-rating, strong FII inflows |
| Base Case Forecast | Rs 267 | In line FY27 earnings, tariff resolution, FII recovery to neutral |
| Bear Case | Rs 163 | FY27 guidance cut, persistent FII outflows, sector de-rating |
Key Risks to the Piramal Pharma Share Price Target 2026
US Tariff Macro Headwind
The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across all Indian equities including Piramal Pharma. This is the key downside risk to the Piramal Pharma share price target 2026 forecast of Rs 267. Monitor trade developments live on the Univest Screener.
Valuation and Earnings Miss Risk
At 55x P/E, Piramal Pharma is priced for consistent execution. Any earnings miss or guidance cut creates disproportionate de-rating risk, the most immediate risk to the Piramal Pharma share price target 2026 of Rs 267. Track earnings on the Univest Screener.
Competitive Pressure in Pharmaceuticals CDMO Consumer Health
Intensifying competition in Pharmaceuticals CDMO Consumer Health may compress Piramal Pharma’s pricing power and market share over the medium term. Subscribe to Univest Pro for SEBI registered research on Piramal Pharma.
FII Selling Pressure and Currency Risk
Global risk off events can trigger institutional selling, disconnecting price from fundamental value. Track live FII/DII flows on the Univest Screener.
How to Invest in Piramal Pharma
- Research on Univest Screener: Search PPLPHARMA at univest.in/screeners for live fundamentals and the latest Piramal Pharma share price target data.
- Open a Demat Account: Buy Piramal Pharma (PPLPHARMA) through any SEBI registered broker. Start on Univest here.
- Plan Your Entry: Key support near Rs 165. First resistance at the lower bound of the Piramal Pharma share price target range of Rs 267.
- Position Sizing: Allocate maximum 3 to 5 percent of your portfolio to any single stock.
- Monitor: Download the Univest App for SEBI registered analyst research alerts on the Piramal Pharma share price target.
FAQs on Piramal Pharma Share Price Target 2026
What is the Piramal Pharma share price target for 2026?
The Piramal Pharma share price target 2026 is Rs 267 based on analyst forecast. Bull case is Rs 343, bear case is Rs 163. Track live on the Univest Screener.
Is Piramal Pharma a good buy at CMP Rs 220?
At Rs 220, Piramal Pharma offers potential upside to the Piramal Pharma share price target 2026 of Rs 267. Depends on your risk tolerance and horizon. Get free research on Univest.
What are the main risks to the Piramal Pharma share price target?
Key risks to the Piramal Pharma share price target of Rs 267 include US tariff macro headwinds, valuation at 55x P/E, competitive dynamics in Pharmaceuticals CDMO Consumer Health, and FII selling. Track on the Univest Screener.
What are the key catalysts for the Piramal Pharma share price target?
Primary catalysts for the Piramal Pharma share price target 2026 include Q4 FY26 results with positive FY27 guidance, RBI rate cuts, Union Budget policy support, and FII flow recovery. Track live on the Univest Screener.
What is the Piramal Pharma share price target for 2027?
For FY27 to FY28, analysts project the Piramal Pharma share price target toward Rs 343 in the bull case. Consult a SEBI registered financial advisor.
Where can I track Piramal Pharma live analyst targets?
Track the Piramal Pharma share price target live at univest.in/screeners. Download the Univest Android App or Univest iOS App.
What is Piramal Pharma 52 week high and low?
Piramal Pharma’s 52 week high is Rs 320 and 52 week low is Rs 165. The current CMP of Rs 220 offers potential upside to the analyst forecast Piramal Pharma share price target 2026 of Rs 267.
How to buy Piramal Pharma shares?
Buy Piramal Pharma (PPLPHARMA) through any SEBI registered broker on NSE. Research the Piramal Pharma share price target on the Univest Screener and download the Univest App for SEBI registered analyst research alerts.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of April 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
Recent Article
Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026
Why Is Ahluwalia Contracts Share Price Falling Key Reasons 2026
Why Is Nuvoco Vistas Corporation Share Price Falling Key Reasons 2026
Why Is Capacite Infraprojects Share Price Falling Key Reasons 2026
